| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 2.956 | 7 | 539 | 8 | 1.170 | 63 | 8 | 8 | 6 |
| Gross Profit/Loss - EUR | 0 | -2.956 | -7 | -539 | -8 | -1.170 | -63 | -8 | -8 | -6 |
| Net Profit/Loss - EUR | 0 | -2.956 | -7 | -539 | -8 | -1.170 | -63 | -8 | -8 | -6 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Teba Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.848 | 1.842 | 1.810 | 1.245 | 1.234 | 40 | 48 | 40 | 42 | 43 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.827 | 1.824 | 1.794 | 1.232 | 1.210 | 27 | 26 | 28 | 30 | 30 |
| Cash | 21 | 18 | 16 | 13 | 24 | 13 | 22 | 12 | 12 | 12 |
| Shareholders Funds | -38.201 | -40.768 | -40.085 | -39.888 | -39.124 | -39.553 | -38.739 | -38.867 | -38.757 | -38.546 |
| Social Capital | 52 | 51 | 50 | 49 | 48 | 48 | 46 | 47 | 46 | 46 |
| Debts | 43.049 | 42.610 | 41.894 | 41.133 | 40.358 | 39.593 | 38.787 | 38.907 | 38.799 | 38.589 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Teba Intermed Srl